Dr. Marian Harris, MD

• Hematopathology

• Anatomic Pathology

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• Harvard Medical School, Molecular Genetic Pathology

  Fellowship Hospital, 2010

• University Of Pennsylvania, Graduate School

  2009

• University Of Pennsylvania

  Medical School, 2009

• Brigham & Women's Hospital, Anatomic Pathology

  Residency Hospital, 2009

• Brigham & Women's Hospital, Hematopathology

  Fellowship Hospital, 2009

• Brigham & Women's Hospital, Hematopathology|harvard Medical School, Molecular Genetic Pathology

  Fellowship Hospital, 2009

• Yale University

  Undergraduate School, 1993

• Identification of Prognostic Factors in Childhood T-Cell Acute Lymphoblastic Leukemia: Results from DFCI ALL Consortium Protocols 05-001 and 11-001, 2020-10-07

• Matched Targeted Therapy for Pediatric Patients with Relapsed, Refractory or High-risk Leukemias: A Report from the LEAP Consortium, 2021-02-09

• SBDS Protein Expression Patterns in the Bone Marrow, 2010-07-15

• Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis, 2012-09-07

• The Public Repository of Xenografts (ProXe) enables discovery and randomized phase II-like trials in mice, 2016-04-11

• Fanconi-BRCA pathway mutations in childhood T-cell acute lymphoblastic leukemia, 2019-11-13

• Mutations in epigenetic regulators including SETD2 are gained during relapse in pediatric acute lymphoblastic leukemia, 2014-03-24

• Hedgehog pathway mutations drive oncogenic transformation in high-risk T-cell acute lymphoblastic leukemia, 2018-03-20

• Genomic and clinical characterization of B/T mixed phenotype acute leukemia reveals recurrent features and T-ALL like mutations, 2018-09-26

• Pediatric Aplastic Anemia and Refractory Cytopenia: A retrospective analysis assessing outcomes and histomorphologic predictors, 2015-03-02